drugset / Trial / NCT01780454

Renal Allograft Tolerance Through Mixed Chimerism

NCT01780454

Phase 1/2 Completed 2 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study will examine the safety and effectiveness of a combination kidney and bone marrow transplant from a haplo-identical related donor. An investigational medication and other treatments will be given prior to and after the transplant to help protect the transplanted kidney from being attacked by the body's immune system

Timeline

Start
2013-03
Primary completion
2018-06
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Background Rituximab Monoclonal antibody
Background Siplizumab Monoclonal antibody